Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01598259Phase 2Terminated
A Phase 2 trial of melatonin in sleep disorder, sponsored by Shriners Children's. Started May 2014; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01598259.